These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 15899104

  • 1. Service utilization and costs of olanzapine versus divalproex treatment for acute mania: results from a randomized, 47-week clinical trial.
    Zhu B, Tunis SL, Zhao Z, Baker RW, Lage MJ, Shi L, Tohen M.
    Curr Med Res Opin; 2005 Apr; 21(4):555-64. PubMed ID: 15899104
    [Abstract] [Full Text] [Related]

  • 2. Divalproex sodium versus olanzapine in the treatment of acute mania in bipolar disorder: health-related quality of life and medical cost outcomes.
    Revicki DA, Paramore LC, Sommerville KW, Swann AC, Zajecka JM, Depakote Comparator Study Group.
    J Clin Psychiatry; 2003 Mar; 64(3):288-94. PubMed ID: 12716270
    [Abstract] [Full Text] [Related]

  • 3. Cost effectiveness of adjunctive quetiapine fumarate extended-release tablets with mood stabilizers in the maintenance treatment of bipolar I disorder.
    Woodward TC, Tafesse E, Quon P, Lazarus A.
    Pharmacoeconomics; 2010 Mar; 28(9):751-64. PubMed ID: 20623994
    [Abstract] [Full Text] [Related]

  • 4. Olanzapine versus divalproex versus placebo in the treatment of mild to moderate mania: a randomized, 12-week, double-blind study.
    Tohen M, Vieta E, Goodwin GM, Sun B, Amsterdam JD, Banov M, Shekhar A, Aaronson ST, Bardenstein L, Grecu-Gabos I, Tochilov V, Prelipceanu D, Oliff HS, Kryzhanovskaya L, Bowden C.
    J Clin Psychiatry; 2008 Nov; 69(11):1776-89. PubMed ID: 19014751
    [Abstract] [Full Text] [Related]

  • 5. Rapid versus non-rapid cycling as a predictor of response to olanzapine and divalproex sodium for bipolar mania and maintenance of remission: post hoc analyses of 47-week data.
    Suppes T, Brown E, Schuh LM, Baker RW, Tohen M.
    J Affect Disord; 2005 Dec; 89(1-3):69-77. PubMed ID: 16253344
    [Abstract] [Full Text] [Related]

  • 6. A rapid and systematic review and economic evaluation of the clinical and cost-effectiveness of newer drugs for treatment of mania associated with bipolar affective disorder.
    Bridle C, Palmer S, Bagnall AM, Darba J, Duffy S, Sculpher M, Riemsma R.
    Health Technol Assess; 2004 May; 8(19):iii-iv, 1-187. PubMed ID: 15147609
    [Abstract] [Full Text] [Related]

  • 7. Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study.
    Tohen M, Ketter TA, Zarate CA, Suppes T, Frye M, Altshuler L, Zajecka J, Schuh LM, Risser RC, Brown E, Baker RW.
    Am J Psychiatry; 2003 Jul; 160(7):1263-71. PubMed ID: 12832240
    [Abstract] [Full Text] [Related]

  • 8. Effectiveness and medical costs of divalproex versus lithium in the treatment of bipolar disorder: results of a naturalistic clinical trial.
    Revicki DA, Hirschfeld RM, Ahearn EP, Weisler RH, Palmer C, Keck PE.
    J Affect Disord; 2005 Jun; 86(2-3):183-93. PubMed ID: 15935238
    [Abstract] [Full Text] [Related]

  • 9. Olanzapine versus divalproex in the treatment of acute mania.
    Tohen M, Baker RW, Altshuler LL, Zarate CA, Suppes T, Ketter TA, Milton DR, Risser R, Gilmore JA, Breier A, Tollefson GA.
    Am J Psychiatry; 2002 Jun; 159(6):1011-7. PubMed ID: 12042191
    [Abstract] [Full Text] [Related]

  • 10. The cost-effectiveness of lamotrigine in the maintenance treatment of adults with bipolar I disorder.
    Calvert NW, Burch SP, Fu AZ, Reeves P, Thompson TR.
    J Manag Care Pharm; 2006 May; 12(4):322-30. PubMed ID: 16792438
    [Abstract] [Full Text] [Related]

  • 11. The safety and early efficacy of oral-loaded divalproex versus standard-titration divalproex, lithium, olanzapine, and placebo in the treatment of acute mania associated with bipolar disorder.
    Hirschfeld RM, Baker JD, Wozniak P, Tracy K, Sommerville KW.
    J Clin Psychiatry; 2003 Jul; 64(7):841-6. PubMed ID: 12934987
    [Abstract] [Full Text] [Related]

  • 12. A comparison of the efficacy, safety, and tolerability of divalproex sodium and olanzapine in the treatment of bipolar disorder.
    Zajecka JM, Weisler R, Sachs G, Swann AC, Wozniak P, Sommerville KW.
    J Clin Psychiatry; 2002 Dec; 63(12):1148-55. PubMed ID: 12523875
    [Abstract] [Full Text] [Related]

  • 13. Predictors of relapse or recurrence in bipolar I disorder.
    Degenhardt EK, Gatz JL, Jacob J, Tohen M.
    J Affect Disord; 2012 Feb; 136(3):733-9. PubMed ID: 22036802
    [Abstract] [Full Text] [Related]

  • 14. Going up in smoke: tobacco smoking is associated with worse treatment outcomes in mania.
    Berk M, Ng F, Wang WV, Tohen M, Lubman DI, Vieta E, Dodd S.
    J Affect Disord; 2008 Sep; 110(1-2):126-34. PubMed ID: 18280579
    [Abstract] [Full Text] [Related]

  • 15. Cost-saving effects of olanzapine as long-term treatment for bipolar disorder.
    Zhang Y.
    J Ment Health Policy Econ; 2008 Sep; 11(3):135-46. PubMed ID: 18806303
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and Safety of Asenapine Versus Olanzapine in Combination With Divalproex for Acute Mania: A Randomized Controlled Trial.
    Mahajan V, Arora M, Tandon VR, Gillani Z, Praharaj SK.
    J Clin Psychopharmacol; 2019 Sep; 39(4):305-311. PubMed ID: 31205195
    [Abstract] [Full Text] [Related]

  • 17. A double blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar mania.
    Yatham LN, Vieta E, Young AH, Möller HJ, Paulsson B, Vågerö M.
    Int Clin Psychopharmacol; 2007 Jul; 22(4):212-20. PubMed ID: 17519644
    [Abstract] [Full Text] [Related]

  • 18. The antidepressant effects of risperidone and olanzapine in bipolar disorder.
    McIntyre RS, Mancini DA, Srinivasan J, McCann S, Konarski JZ, Kennedy SH.
    Can J Clin Pharmacol; 2004 Jul; 11(2):e218-26. PubMed ID: 15520475
    [Abstract] [Full Text] [Related]

  • 19. The role of divalproex plus olanzapine in outpatient mixed-episode bipolar I disorder.
    Goldberg JF.
    J Clin Psychiatry; 2009 Nov; 70(11):1548-50. PubMed ID: 20031096
    [No Abstract] [Full Text] [Related]

  • 20. Rates of remission/euthymia with quetiapine in combination with lithium/divalproex for the treatment of acute mania.
    Sussman N, Mullen J, Paulsson B, Vågerö M.
    J Affect Disord; 2007 Nov; 100 Suppl 1():S55-63. PubMed ID: 17383736
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.